首页> 外文期刊>Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis >Induction of granulocytic differentiation in acute promyelocytic leukemia cells (HL-60) by water-soluble chitosan oligomer.
【24h】

Induction of granulocytic differentiation in acute promyelocytic leukemia cells (HL-60) by water-soluble chitosan oligomer.

机译:水溶性壳聚糖低聚物诱导急性早幼粒细胞白血病细胞(HL-60)中的粒细胞分化。

获取原文
获取原文并翻译 | 示例
           

摘要

Water-soluble chitosan oligomer (WSCO) has been reported to have anticancer activity, immuno-enhancing effect and antimicrobial activity. However, other biological activities are unknown. Herein, we have shown that WSCO is able to inhibit proliferation of human leukemia HL-60 cells and induce these cells to differentiate. Treatment with WSCO for 4 days resulted in a concentration-dependent reduction in HL-60 cell growth as measured by cell counting and MTT assay. This effect was accompanied by a marked increase in the proportion of G(0)/G(1) cells as measured by flow cytometry. WSCO also induced differentiation of the cells as measured by phorbol ester-dependent reduction of NBT, morphological changes as examined by Wright-Giemsa staining and expression of CD11b but not of CD14 as analysed by flow cytometry, indicating differentiation of HL-60 cells toward granulocyte-like cells. A combination of low dose of WSCO with all-trans retinoic acid, a differentiating agent toward granulocyte-like cells, exhibited a synergistic effect on the differentiation. In addition, treatment of HL-60 cells with WSCO for 6 or 8 days resulted in the induction of apoptosis as assayed qualitatively by agarose gel electrophoresis and quantitatively by Annexin V technique using flow cytometry. Collectively, there is a potential for WSCO in the treatment of myeloid leukemia.
机译:水溶性壳聚糖低聚物(WSCO)据报道具有抗癌活性,免疫增强作用和抗微生物活性。但是,其他生物活性未知。在本文中,我们已显示WSCO能够抑制人白血病HL-60细胞的增殖并诱导这些细胞分化。 WSCO处理4天后,通过细胞计数和MTT分析测定,HL-60细胞生长呈浓度依赖性降低。通过流式细胞术测量,该效果伴随着G(0)/ G(1)细胞比例的显着增加。 WSCO还可以通过佛波酯依赖性的NBT还原,Wright-Giemsa染色和CD11b而不是CD14的表达(通过流式细胞仪分析)检测到的形态变化来诱导细胞分化,这表明HL-60细胞向粒细胞分化样细胞。低剂量的WSCO与全反式视黄酸(一种向粒细胞样细胞的分化剂)的组合对分化具有协同作用。另外,用琼脂糖凝胶电泳定性测定,用流式细胞术通过膜联蛋白V技术定量测定,用WSCO处理HL-60细胞6天或8天导致细胞凋亡的诱导。总体而言,WSCO在治疗骨髓性白血病中具有潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号